Collyer Law LLC advised a venture capital fund on its investment in the Series A fundraising round of a synthetic biotechnology start-up that develops livestock disease prevention biotechnology. The start-up offers recombinant custom peptides cultivated using synbio microorganisms as an antibiotic replacement for disease prevention and growth promotion in livestock, providing breeders and farmers with humane, sustainable, highly productive agriculture without the use of antib

Collyer Law is advising InfraRiskSG Pte. Ltd. (dba, InfraRisk), a Singapore-based FinTech company with operations in Australia and the...

Collyer Law is advising an India-based financing corporation for the infrastructure and energy sectors in its role as Singapore legal...

Now in its 19th year, India Business Law Journal celebrates the standout India-focused achievements of law firms worldwide. This annual...

Collyer Law advised TripleDot Studios on the acquisition of the mobile gaming business of AppLovin Corporation (NASDAQ: APP)...